No significant differences were observed in tumor number, tumor size, alpha-fetoprotein levels, portal hypertension, and albumin levels between the Res and Non-Res groups, suggesting that there were no established confounding variables causing discrimination between the groups before sample gathering. The gene discussed is AFP; the disease is liver disorder.